Aprotinin during coronary-artery bypass grafting and risk of death

Article Abstract:

A study to examine whether the use of Aprotinin during coronary-artery bypass grafting surgery can lead to in-hospital death is conducted. Results conclude that those patients that were administered Aprotinin on the day of surgery had a greater risk of mortality as compared to those who were not given Aprotinin.

---

Learning from Aprotinin - mandatory trials of comparative efficacy and safety needed

Article Abstract:

The article discusses the efficacy of Aprotinin, a drug for use in coronary-artery bypass grafting after observing that it results in an increased mortality rate. Suggestions are made for mandatory trials to test the efficacy of any new drugs that may be dangerous in the long run and lead to mortality.

Editorial, Analysis, Clinical trials

---

The effect of Aprotinin on outcome after coronary-artery bypass grafting

Article Abstract:

A study to examine the resulting outcome after the use of Aprotinin on patients having undergone coronary-artery bypass grafting surgery is conducted. Results indicate that those patients that were given Aprotinin had a higher mortality rate and increases in serum creatinine levels.

Health aspects, Creatinine

Similar abstracts:

• Abstracts: A pioneering Primary Care nursing service. Shared experience. 'Rami's enthusiasm was truly inspiring'
• Abstracts: Dealing with conflict in caring for the seriously III: "It was just out of the question". Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence
• Abstracts: Antidepressant and pediatric depression - the risk of doing nothing. Late-life depression
• Abstracts: Tooth sensitivity related to class I and II resin restorations
• Abstracts: Prophylaxis strategies for contrast-induced nephropathy. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.